S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.54
+1.86
+11.15%
ELAN · Elanco Animal Health Incorporated
NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD
Elanco Animal Health Inc (ELAN)
NEW YORK STOCK EXCHANGE, INC.
Pharmaceuticals
$22.55
-0.13
(-0.57%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$22.55
$22.23
$22.98
52-WEEK RANGE
$22.55
$19.40
$27.98
What's happening
- ELAN is down 0.57% today, trading at $22.55. — Live quote
- Volume today (427,019) is well below its 3-month average of 5,793,470. (Finnhub fundamentals)
- Reports earnings on 2026-11-06 (before market open), 15 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.34 actual vs. $0.27 estimated (+23.8%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 9
Buy 11
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (22 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ELAN
-0.35%
vs S&P 500
-13.72%
1-YEAR RETURN
ELAN
+4.30%
vs S&P 500
-10.86%
6-MONTH RETURN
ELAN
-4.77%
3-MONTH RETURN
ELAN
-11.01%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.34
Est. $0.27
BEAT +23.8%
2026-04-26 (Q1 2026)
$0.40
Est. $0.35
BEAT +13.4%
2026-01-26 (Q4 2025)
$0.13
Est. $0.11
BEAT +15.0%
2025-10-26 (Q3 2025)
$0.19
Est. $0.13
BEAT +43.0%
Valuation Measures & Ratios
Enterprise Value4$14.58B
Forward P/E519.80
PEG Ratio6—
Price / Sales (TTM1)2.23
Price / Book71.87
EV4 / Revenue2.90
EV4 / EBITDA37.48
Profit Margin-3.96%
Operating Margin-3.33%
Return on Equity (ROE8)-3.02%
Return on Assets (ROA9)-1.48%
Avg Volume (3M)5,793,470
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $12.09B | $12.40B | $9.79B | $7.86B | $5.41B |
| P/E | 137.34 | 122.80 | 23.99 | 20.06 | 13.10 |
| Price/Sales | 2.36 | 2.51 | 2.13 | 1.69 | 1.17 |
| Price/Book | 1.83 | 1.91 | 1.45 | 1.16 | 0.85 |
| EV/Revenue | 2.97 | 3.18 | 2.84 | 2.43 | 2.03 |
| ROE | 1.34% | 1.55% | 6.05% | 5.79% | 6.50% |
| ROA | 0.65% | 0.76% | 3.01% | 2.85% | 3.19% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short37,291,528
Change from Prior Settlement+17.24%
% of Float—
Days to Cover (Short Ratio)6.16
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 10.2% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +4.3%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -4.0%. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-20; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ELAN
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.37B | $1.37B | $1.14B | $1.24B | $1.19B | $1.03B | $1.18B | $1.21B |
| Gross profit | $798.0M | $785.0M | $607.0M | $713.0M | $684.0M | $538.0M | $689.0M | $690.0M |
| Net income | $54.0M | $57.0M | -$34.0M | $11.0M | $67.0M | $364.0M | -$50.0M | $32.0M |
| EPS (diluted) | $0.11 | $0.11 | $-0.07 | $0.02 | $0.13 | $0.73 | $-0.10 | $0.06 |
| EPS (basic) | $0.11 | $0.11 | $-0.07 | $0.02 | $0.14 | $0.74 | $-0.10 | $0.06 |
| Net margin | $4 | $4 | -$3 | $1 | $6 | $35 | -$4 | $3 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $13.56B | $13.22B | $13.36B | $13.55B | $13.74B | $12.94B | $12.61B | $13.28B |
| Total liabilities | $6.97B | $6.72B | $6.81B | $6.80B | $6.97B | $6.59B | $6.52B | $6.76B |
| Stockholders' equity | $6.59B | $6.50B | $6.55B | $6.75B | $6.78B | $6.35B | $6.10B | $6.52B |
| Total current assets | $3.80B | $3.58B | $3.46B | $3.49B | $3.61B | $3.44B | $3.21B | $3.37B |
| Total current liabilities | $1.85B | $1.66B | $1.60B | $1.46B | $1.39B | $1.27B | $1.31B | $1.32B |
| Cash & equivalents | $530.0M | $428.0M | $545.0M | $505.0M | $539.0M | $487.0M | $468.0M | $490.0M |
| Accounts receivable | $1.08B | $1.08B | $873.0M | $894.0M | $989.0M | $970.0M | $805.0M | $840.0M |
| Inventory | $1.77B | $1.72B | $1.74B | $1.71B | $1.67B | $1.59B | $1.57B | $1.63B |
| Property, plant & equipment | $1.41B | $1.40B | $1.41B | $1.39B | $1.36B | $1.05B | $993.0M | $979.0M |
| Goodwill | $4.84B | $4.72B | $4.78B | $4.76B | $4.76B | $4.51B | $4.41B | $4.62B |
| Intangible assets | $3.20B | $3.23B | $3.41B | $3.60B | $3.71B | $3.63B | $3.68B | $4.01B |
| Other non-current assets | $304.0M | $295.0M | $304.0M | $306.0M | $308.0M | $312.0M | $311.0M | $302.0M |
| Accounts payable | $427.0M | $372.0M | $368.0M | $352.0M | $368.0M | $330.0M | $296.0M | $259.0M |
| Deferred revenue (current) | $450.0M | $400.0M | $416.0M | $376.0M | $367.0M | $319.0M | $332.0M | $333.0M |
| Short-term debt | — | — | — | — | — | $44.0M | $44.0M | $44.0M |
| Other current liabilities | $902.0M | $817.0M | $739.0M | $665.0M | $596.0M | $576.0M | $466.0M | $685.0M |
| Long-term debt | $3.66B | $3.74B | $3.76B | $3.77B | $3.95B | $4.39B | $4.32B | $4.36B |
| Other non-current liabilities | $551.0M | $467.0M | $585.0M | $607.0M | $638.0M | $487.0M | $302.0M | $587.0M |
| Common stock & paid-in capital | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained earnings | -$2.07B | -$2.12B | -$2.18B | -$1.91B | -$1.87B | -$1.88B | -$1.95B | -$1.94B |
| Accumulated other comprehensive income (loss) | -$219.0M | -$233.0M | -$141.0M | -$199.0M | -$192.0M | -$583.0M | -$771.0M | -$339.0M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $277.0M | $13.0M | $108.0M | $219.0M | $237.0M | -$4.0M | $177.0M | $162.0M |
| Investing cash flow | -$110.0M | -$60.0M | -$64.0M | -$101.0M | -$56.0M | -$58.0M | -$90.0M | $1.24B |
| Financing cash flow | -$74.0M | -$65.0M | -$18.0M | -$153.0M | -$156.0M | $52.0M | -$32.0M | -$1.34B |
| Free cash flow | $244.0M | -$38.0M | $46.0M | $127.0M | $180.0M | -$69.0M | $130.0M | $120.0M |
| Capital expenditures | $33.0M | $51.0M | $62.0M | $92.0M | $57.0M | $65.0M | $47.0M | $42.0M |
| Depreciation & amortization | $171.0M | $172.0M | $174.0M | $176.0M | $169.0M | $161.0M | $164.0M | $170.0M |
| Share-based compensation | $20.0M | $21.0M | $16.0M | $17.0M | $20.0M | $15.0M | $15.0M | $15.0M |
| Deferred income taxes | — | — | -$134.0M | — | — | — | -$112.0M | — |
| Change in inventory | — | — | $57.0M | — | — | — | -$44.0M | — |
| Other investing activities | $1.0M | $9.0M | $2.0M | $9.0M | -$1.0M | $2.0M | $2.0M | $8.0M |
| Tax withholding on stock comp | $1.0M | $34.0M | — | — | $1.0M | $13.0M | — | — |
| Other financing activities | $0 | -$15.0M | -$17.0M | $21.0M | $1.0M | -$7.0M | $6.0M | -$8.0M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $4.71B | $4.44B | $4.42B | $4.41B | $4.76B |
| Gross profit | $2.59B | $2.44B | $2.49B | — | — |
| Net income | -$232.0M | $338.0M | -$1.23B | -$78.0M | -$483.0M |
| EPS (diluted) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 |
| EPS (basic) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 |
| Net margin | -$5 | $8 | -$28 | -$2 | -$10 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $13.36B | $12.61B | $14.36B | $15.49B | $16.48B |
| Total liabilities | $6.81B | $6.52B | $8.14B | $8.20B | $8.97B |
| Stockholders' equity | $6.55B | $6.10B | $6.22B | $7.29B | $7.51B |
| Total current assets | $3.46B | $3.21B | $3.41B | $3.28B | $3.27B |
| Total current liabilities | $1.60B | $1.31B | $1.24B | $1.70B | $1.65B |
| Cash & equivalents | $545.0M | $468.0M | $352.0M | $345.0M | $638.0M |
| Accounts receivable | $873.0M | $805.0M | $842.0M | $797.0M | $833.0M |
| Inventory | $1.74B | $1.57B | $1.74B | $1.54B | $1.37B |
| Property, plant & equipment | — | $993.0M | $1.03B | $999.0M | $1.05B |
| Goodwill | $4.78B | $4.41B | $5.09B | $5.99B | $6.17B |
| Intangible assets | $3.41B | $3.68B | $4.49B | $4.84B | $5.59B |
| Other non-current assets | $304.0M | $311.0M | $341.0M | $378.0M | $390.0M |
| Accounts payable | $368.0M | $296.0M | $270.0M | $390.0M | $416.0M |
| Deferred revenue (current) | $416.0M | $332.0M | $367.0M | $324.0M | $319.0M |
| Short-term debt | — | $44.0M | $38.0M | $388.0M | $294.0M |
| Other current liabilities | $533.0M | $466.0M | $409.0M | $454.0M | $433.0M |
| Long-term debt | $3.76B | $4.32B | $5.77B | $5.84B | $6.32B |
| Other non-current liabilities | $427.0M | $302.0M | $411.0M | $229.0M | $262.0M |
| Common stock & paid-in capital | $0 | $0 | $0 | $0 | $0 |
| Retained earnings | -$2.18B | -$1.95B | -$2.29B | -$1.06B | -$979.0M |
| Accumulated other comprehensive income (loss) | -$141.0M | -$771.0M | -$266.0M | -$392.0M | -$209.0M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $560.0M | $541.0M | $271.0M | $452.0M | $483.0M |
| Investing cash flow | -$279.0M | $1.16B | -$169.0M | -$179.0M | -$530.0M |
| Financing cash flow | -$275.0M | -$1.49B | -$83.0M | -$549.0M | $210.0M |
| Free cash flow | $284.0M | $394.0M | $131.0M | $281.0M | $324.0M |
| Capital expenditures | $276.0M | $147.0M | $140.0M | $171.0M | $159.0M |
| Depreciation & amortization | $680.0M | $662.0M | $694.0M | $682.0M | $716.0M |
| Share-based compensation | $68.0M | $55.0M | $46.0M | $59.0M | $66.0M |
| Deferred income taxes | -$134.0M | -$112.0M | -$80.0M | -$57.0M | -$148.0M |
| Change in inventory | $57.0M | -$44.0M | $160.0M | $269.0M | -$29.0M |
| Other investing activities | $12.0M | $14.0M | $10.0M | $8.0M | -$9.0M |
| Other financing activities | -$2.0M | -$17.0M | -$6.0M | -$32.0M | -$31.0M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ELAN as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers93.2%
Shares Outstanding499,549,698
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| DODGE & COX | 67,397,025 | $1.66B | 13.49% | -2.2% | 2026-08-13 |
| FMR LLC | 56,948,819 | $1.40B | 11.40% | +11.8% | 2026-08-13 |
| BlackRock, Inc. | 48,849,973 | $1.20B | 9.78% | +2.6% | 2026-08-07 |
| PRIMECAP MANAGEMENT CO/CA/ | 45,445,012 | $1.12B | 9.10% | -0.9% | 2026-08-14 |
| T. Rowe Price Investment Management, Inc. | 28,750,719 | $707.6K | 5.76% | -17.0% | 2026-08-14 |
| DIMENSIONAL FUND ADVISORS LP | 25,417,271 | $625.5M | 5.09% | +3.6% | 2026-08-11 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 22,672,312 | $558.0M | 4.54% | +0.2% | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 22,607,532 | $556.4M | 4.53% | +1.2% | 2026-06-30 |
| State Street Corp | 16,063,046 | $395.3M | 3.22% | +4.7% | 2026-08-07 |
| Winslow Capital Management, LLC | 13,511,127 | $332.5M | 2.70% | -0.8% | 2026-08-13 |
| Black Creek Investment Management Inc. | 13,046,420 | $321.1M | 2.61% | +24.3% | 2026-08-12 |
| GEODE CAPITAL MANAGEMENT, LLC | 11,302,057 | $278.2M | 2.26% | +1.0% | 2026-08-12 |
| UBS Group AG | 9,910,822 | $243.9M | 1.98% | +15.6% | 2026-08-13 |
| CITADEL ADVISORS LLC | 9,668,611 | $237.9M | 1.94% | +120.4% | 2026-08-14 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 8,355,772 | $205.6M | 1.67% | +34.1% | 2026-08-12 |
| Morgan Stanley | 7,854,362 | $193.3M | 1.57% | +22.4% | 2026-08-11 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 6,240,240 | $153.6M | 1.25% | +3.7% | 2026-08-12 |
| Invesco Ltd. | 5,306,326 | $130.6M | 1.06% | -34.8% | 2026-08-13 |
| Sei Investments Co | 5,284,773 | $130.1M | 1.06% | -6.5% | 2026-08-14 |
| JENNISON ASSOCIATES LLC | 4,508,395 | $111.0M | 0.90% | +44.5% | 2026-08-03 |
| MARSHALL WACE, LLP | 4,432,350 | $109.1M | 0.89% | +220.6% | 2026-08-13 |
| Northern Trust Corp | 4,256,056 | $104.7M | 0.85% | +1.6% | 2026-08-12 |
| JUPITER ASSET MANAGEMENT LTD | 4,219,279 | $103.8M | 0.84% | +35.7% | 2026-08-10 |
| Bank Of America Corp /De/ | 3,909,871 | $96.2M | 0.78% | +16.4% | 2026-08-14 |
| Clearbridge Investments, LLC | 3,716,181 | $91.5M | 0.74% | -18.9% | 2026-08-10 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Insider activity is not available for this symbol right now.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 09:15 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-20 | 4 | 2026-10-16 | View on SEC.gov → |
| 2026-10-20 | 4 | 2026-10-16 | View on SEC.gov → |
| 2026-10-20 | 4 | 2026-10-16 | View on SEC.gov → |
| 2026-10-19 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-10-06 | 4 | 2026-10-02 | View on SEC.gov → |
| 2026-10-06 | 4 | 2026-10-02 | View on SEC.gov → |
| 2026-10-06 | 4 | 2026-10-02 | View on SEC.gov → |
| 2026-10-01 | 4 | 2026-09-30 | View on SEC.gov → |
| 2026-09-22 | 4 | 2026-09-18 | View on SEC.gov → |
| 2026-09-22 | 4 | 2026-09-18 | View on SEC.gov → |
| 2026-09-22 | 4 | 2026-09-18 | View on SEC.gov → |
| 2026-09-09 | 4 | 2026-09-04 | View on SEC.gov → |
Recent news
Headlines about ELAN (Elanco Animal Health Incorporated). Links open the publisher — we don’t host full articles.
-
Elanco (ELAN) Stock Could Be 49% Undervalued Despite Zenrelia Growth
Simply Wall Street · 2026-10-22 -
How Unusual Is Zoetis's Latest Sales Growth?
Yahoo · 2026-10-22 -
This Chipotle Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Benzinga · 2026-10-21 -
ELAN Apr 2027 15.000 call (ELAN270416C00015000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-21 -
Elanco Animal Health Inc (ELAN) Shares Fall 3.4% -- What GF Scor
GuruFocus · 2026-10-20 -
Elanco Animal Health Slides as Analyst Downgrade Pressures Shares
Quiver Quantitative · 2026-10-20 -
Elanco CFO Robert VanHimbergen Purchases 8.366 Deferred Stock Units at $23.55 Each
Kalkine Media · 2026-10-20 -
An executive receives 62.7147 stock units in an Elanco (ELAN) award priced at $23.55 per unit.
Stock Titan · 2026-10-20
No headlines in this category right now — try “All”.